Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Octreotide ER by Debiopharm International for Acromegaly: Likelihood of Approval
Octreotide ER is under clinical development by Debiopharm International and currently in Phase II for Acromegaly. According to GlobalData, Phase...